These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22329507)

  • 1. Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.
    Tamayo NA; Bo Y; Gore V; Ma V; Nishimura N; Tang P; Deng H; Klionsky L; Lehto SG; Wang W; Youngblood B; Chen J; Correll TL; Bartberger MD; Gavva NR; Norman MH
    J Med Chem; 2012 Feb; 55(4):1593-611. PubMed ID: 22329507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
    Parks DJ; Parsons WH; Colburn RW; Meegalla SK; Ballentine SK; Illig CR; Qin N; Liu Y; Hutchinson TL; Lubin ML; Stone DJ; Baker JF; Schneider CR; Ma J; Damiano BP; Flores CM; Player MR
    J Med Chem; 2011 Jan; 54(1):233-47. PubMed ID: 21128593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.
    Horne DB; Tamayo NA; Bartberger MD; Bo Y; Clarine J; Davis CD; Gore VK; Kaller MR; Lehto SG; Ma VV; Nishimura N; Nguyen TT; Tang P; Wang W; Youngblood BD; Zhang M; Gavva NR; Monenschein H; Norman MH
    J Med Chem; 2014 Apr; 57(7):2989-3004. PubMed ID: 24597733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.
    Zhu B; Xia M; Xu X; Ludovici DW; Tennakoon M; Youngman MA; Matthews JM; Dax SL; Colburn RW; Qin N; Hutchinson TL; Lubin ML; Brandt MR; Stone DJ; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2234-7. PubMed ID: 23411075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels.
    Ma S; G G; Ak VE; Jf D; H H
    Pak J Pharm Sci; 2008 Oct; 21(4):370-8. PubMed ID: 18930858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
    Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
    J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camphor activates and sensitizes transient receptor potential melastatin 8 (TRPM8) to cooling and icilin.
    Selescu T; Ciobanu AC; Dobre C; Reid G; Babes A
    Chem Senses; 2013 Sep; 38(7):563-75. PubMed ID: 23828908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMG2850, a potent and selective TRPM8 antagonist, is not effective in rat models of inflammatory mechanical hypersensitivity and neuropathic tactile allodynia.
    Lehto SG; Weyer AD; Zhang M; Youngblood BD; Wang J; Wang W; Kerstein PC; Davis C; Wild KD; Stucky CL; Gavva NR
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Apr; 388(4):465-76. PubMed ID: 25662185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.
    Matthews JM; Qin N; Colburn RW; Dax SL; Hawkins M; McNally JJ; Reany L; Youngman MA; Baker J; Hutchinson T; Liu Y; Lubin ML; Neeper M; Brandt MR; Stone DJ; Flores CM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2922-6. PubMed ID: 22421018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
    Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
    J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.
    Ohmi M; Shishido Y; Inoue T; Ando K; Fujiuchi A; Yamada A; Watanabe S; Kawamura K
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5364-8. PubMed ID: 25455182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels.
    Ortar G; De Petrocellis L; Morera L; Moriello AS; Orlando P; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2010 May; 20(9):2729-32. PubMed ID: 20378345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
    Chaudhari SS; Kadam AB; Khairatkar-Joshi N; Mukhopadhyay I; Karnik PV; Raghuram A; Rao SS; Vaiyapuri TS; Wale DP; Bhosale VM; Gudi GS; Sangana RR; Thomas A
    Bioorg Med Chem; 2013 Nov; 21(21):6542-53. PubMed ID: 24055075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of transient receptor potential melastatin 8 activation by phthalate esters that enhance contact hypersensitivity in mice.
    Kurohane K; Sahara Y; Kimura A; Narukawa M; Watanabe T; Daimon T; Imai Y
    Toxicol Lett; 2013 Mar; 217(3):192-6. PubMed ID: 23296101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential channel TRPM8 agonists stimulate calcium influx and neurotensin secretion in neuroendocrine tumor cells.
    Mergler S; Strowski MZ; Kaiser S; Plath T; Giesecke Y; Neumann M; Hosokawa H; Kobayashi S; Langrehr J; Neuhaus P; Plöckinger U; Wiedenmann B; Grötzinger C
    Neuroendocrinology; 2007; 85(2):81-92. PubMed ID: 17426390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
    De Petrocellis L; Vellani V; Schiano-Moriello A; Marini P; Magherini PC; Orlando P; Di Marzo V
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1007-15. PubMed ID: 18354058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.
    Calvo RR; Meegalla SK; Parks DJ; Parsons WH; Ballentine SK; Lubin ML; Schneider C; Colburn RW; Flores CM; Player MR
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1903-7. PubMed ID: 22330635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of icilin- and cold-evoked responses of spinal neurones, and their modulation of mechanical activity, in a model of neuropathic pain.
    Brignell JL; Chapman V; Kendall DA
    Brain Res; 2008 Jun; 1215():87-96. PubMed ID: 18479674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
    Doherty EM; Fotsch C; Bannon AW; Bo Y; Chen N; Dominguez C; Falsey J; Gavva NR; Katon J; Nixey T; Ognyanov VI; Pettus L; Rzasa RM; Stec M; Surapaneni S; Tamir R; Zhu J; Treanor JJ; Norman MH
    J Med Chem; 2007 Jul; 50(15):3515-27. PubMed ID: 17585750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel.
    Chuang HH; Neuhausser WM; Julius D
    Neuron; 2004 Sep; 43(6):859-69. PubMed ID: 15363396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.